pharmaphorum

JUNE 27, 2016

The ASCO Annual Meeting, the largest global oncology meeting and increasingly the centre of a kaleidoscope of social media coverage each year. This webinar will examine the conversation around ASCO 2016, its relationship with ASCO, value to and involvement from stakeholder groups and how it will potentially continue to evolve into 2017.

Media 52

Media Medical Pharma 52

pharmaphorum

JULY 7, 2022

ASCO 2022: Checkpoint inhibitors, Enhertu in spotlight. pharmaphorum editor in chief Jonah Comstock rounds up key developments from the American Society of Clinical Oncology’s first in-person conference since COVID began. Read Deep Dive: Oncology in full.

Healthcare Provider 52

Healthcare Provider Physicians Healthcare Healthcare 52

pharmaphorum

AUGUST 15, 2022

At this year’s ASCO congress, the Trop2-targeting antibody-drug conjugate (ADC) was found to improve progression-free survival significantly in in patients with hormone receptor-positive, HER2-negative metastatic breast cancer who received multiple lines of prior treatment.

Prospecting 65

Prospecting Sales Medical Patients 65

pharmaphorum

JULY 25, 2022

Enhertu also has a six-month priority review from the US regulator, so a decision on its new use in metastatic, HER2-low breast cancer should be made within six months.

FDA 57

FDA Sales territory Sales Patients 57

PM360

AUGUST 9, 2022

Doctor Docs: Oncologists React to ASCO Educational Material. Following the annual American Society of Clinical Oncology (ASCO) conference, oncologists were asked how the data presented would impact their care of patients.

Healthcare 52

Healthcare Healthcare Food and Drug Administration FDA 52

Pharma Marketing Network

JANUARY 19, 2022

If a brand talks at conferences are doctors going to hear it? Talkie” ads on ililli at ASCO got an 18% CTR. Thousands of ophthalmologists heard talks about the AAO. Those talks played for nearly 70 hours. That’s a lot of media. A lot of talk. The kind of media that a brand would like to be part of. They had 300×600 banner ad.

Doctors 97

Doctors Media Distribution Pharma 97

Legacy MEDSearch

JANUARY 3, 2023

Burning Rock started development of multi-cancer early detection technology based on DNA methylation in 2016, and the technology and validation data have been presented at ASCO , ESMO and other medical conferences, as well as journals such as Nature Biomedical Engineering [1] , demonstrating high specificity, sensitivity, and accuracy in predicting (..)

FDA 95

FDA Food and Drug Administration Recruitment Prospecting 95

Clarivate

AUGUST 8, 2023

The law was top-of-mind at this summer’s ASCO and BIO meetings, tentpole events in the biopharma conference calendar. The biopharma industry is sweating the long-term implications and warning that it could mean less lifesaving drugs make it to patients going forward.

Biopharma 52

Biopharma Pharma Prescription Manufacturing 52

Clarivate

OCTOBER 7, 2021

As part of our Drugs to Watch series, which reviews therapies expected to have significant impact on healthcare markets, Clarivate oncology experts sifted through the more than 2,800 abstracts that were accepted for presentation at the ESMO 2021 Virtual Conference and selected their top picks.

Patients 91

Patients Safety Marketing Physicians 91

Pharmaceutical Technology

JUNE 6, 2023

Following the publication of clinical data from its Phase I study of the inhibitor at the American Society of Clinical Oncology (ASCO) conference, Ellipses was motivated to accelerate clinical development due to what it believes are “very encouraging” results. The ASCO Annual Meeting is being held 2–6 June in Chicago.

Pharma 52

Pharma Patients Prospecting Competition 52

Pharmaceutical Technology

JUNE 5, 2023

In results presented at the ongoing American Society of Clinical Oncology (ASCO) Annual Meeting , Summit reported an overall response rate (ORR) of 67% in NSCLC patients with squamous histology treated with its lead drug ivonescimab plus chemotherapy. The ASCO conference is being held 2–6 June in Chicago.

Side effects 52

Side effects Patients Leads Prospecting 52